Cerebral metabolic stimulant; shows antihypoxic effects. Vasodilator.
Product Details
Alternative Name: | (3α,16α)-Eburnamenin-14(15H)-one, Vincamone, Vinburnine |
|
Formula: | C19H22N2O |
|
MW: | 294.4 |
|
CAS: | 4880-88-0 |
|
MI: | 14: 3487 |
|
RTECS: | YY8575570 |
|
Purity: | ≥99% (Assay) |
|
Appearance: | White to slightly yellow crystalline powder. |
|
Solubility: | Soluble in chloroform. |
|
Shipping: | Ambient |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Asymmetric synthesis of (-)-eburnamonine and (+)-epi-eburnamonine from (4S)-4-ethyl-4-[2-(hydroxycarbonyl)ethyl]-2-butyrolactone: A.G. Wee & Q. Yu; J. Org. Chem.
66, 8935 (2001),
Abstract;
Experimental clinical studies on the effect of eburnamonine in cerebrovascular disorders: W. Jansen, et al.; Pharmacopsychiatry
19, 389 (1986),
Abstract;
’Cerebroactive’ drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders: A. Spagnoli & G. Tognoni; Drugs
26, 44 (1983), Review,
Abstract;
Experimental approach of activity and mechanism(s) of action of drugs used in cerebral metabolic insufficiency. Application to 1-eburnamonine: P. Linee, et al.; Eur. Neurol.
20, 253 (1981),
Abstract;